Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Robustness of cancer microbiome signals over a broad range of methodological variation.
Sepich-Poore GD, McDonald D, Kopylova E, Guccione C, Zhu Q, Austin G, Carpenter C, Fraraccio S, Wandro S, Kosciolek T, Janssen S, Metcalf JL, Song SJ, Kanbar J, Miller-Montgomery S, Heaton R, Mckay R, Patel SP, Swafford AD, Korem T, Knight R. Sepich-Poore GD, et al. Among authors: mckay r. Oncogene. 2024 Apr;43(15):1127-1148. doi: 10.1038/s41388-024-02974-w. Epub 2024 Feb 23. Oncogene. 2024. PMID: 38396294 Free PMC article.
Correction: Robustness of cancer microbiome signals over a broad range of methodological variation.
Sepich-Poore GD, McDonald D, Kopylova E, Guccione C, Zhu Q, Austin G, Carpenter C, Fraraccio S, Wandro S, Kosciolek T, Janssen S, Metcalf JL, Song SJ, Kanbar J, Miller-Montgomery S, Heaton R, Mckay R, Patel SP, Swafford AD, Korem T, Knight R. Sepich-Poore GD, et al. Among authors: mckay r. Oncogene. 2024 May;43(20):1579. doi: 10.1038/s41388-024-03018-z. Oncogene. 2024. PMID: 38580705 Free PMC article. No abstract available.
Cancer, more than a "COVID-19 co-morbidity".
Jani CT, Schooley RT, Mckay RR, Lippman SM. Jani CT, et al. Among authors: mckay rr. Front Oncol. 2023 Mar 13;13:1107384. doi: 10.3389/fonc.2023.1107384. eCollection 2023. Front Oncol. 2023. PMID: 36994197 Free PMC article. Review.
Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease.
Sarkar RR, Patel SH, Parsons JK, Deka R, Kumar A, Einck JP, Mundt AJ, Kader AK, Kane CJ, Riviere P, McKay R, Murphy JD, Rose BS. Sarkar RR, et al. Among authors: mckay r. Prostate Cancer Prostatic Dis. 2020 Dec;23(4):689-695. doi: 10.1038/s41391-020-0241-3. Epub 2020 Jun 8. Prostate Cancer Prostatic Dis. 2020. PMID: 32513967
1,425 results